TABLE 4.
Clinicopathologic features of napsin A-positive large cell neuroendocrine carcinomas.
| Age | Gender | Smoking pack years | Tumor Size (cm) | pTNM stage at resection | Vital status | |
|---|---|---|---|---|---|---|
| Case 1 | 58 | F | 20 | 2.5 | IIIA | na |
| Case 2 | 58 | M | 80 | 4.5 | IB | DOD (1 year survival) |
| Case 3 | 66 | M | 100 | 10.2 | IIIA | DOD (1 year survival) |
| Case 4 | 59 | F | 39 | 5.0 | IIB | NED (8 years follow-up) |
| Case 5 | 54 | M | 40 | 2.8 | IA | NED (8 years follow-up) |
| Case 6 | 73 | M | na | 5.5 | IIIA | na |
| Case 7 | 66 | F | 40 | 1.6 | IIA | DOD (4 year survival) |
| Case 8 | 64 | F | 17 | 1.1 | IA | DOO (16 years follow-up) |
| Case 9 | 73 | F | 50 | 4.6 | IB | DOD (4 yr survival) |
| Case 10 | 51 | F | 15 | 6 | IIIA | DOD (1.5 yr survival) |
| Case 11 | 53 | F | 15 | 6.2 | IIIA | NED (6 yr follow-up) |
| Case 12 | 68 | M | 37.5 | 4.5 | IB | DOD (2 yr survival) |
| Case 13 | 67 | F | 0 | 1.6 | IB | DOD (3 yr survival) |
| Case 14 | 67 | F | 45 | 4.6 | IB | NED (4 yr follow-up) |
| Case 15 | 67 | F | 98 | 5.2 | IB | NED (3 yr follow-up) |
| Case 16 | 79 | F | 62.5 | 2.1 | IA | AWD (1 yr follow-up) |
| Case 17 | 65 | M | 46 | 7.8 | IIB | NED (2 yr follow-up) |
| Summary: | Mean (range): 64 (51-79) |
F:M ratio: 11:6 |
Mean (range): 44 (0-100) |
Mean (range): 4.5 (1-10) |
% stage I: 53% |
% disease recurrence and/or death of disease: 53% |
NED = no evidence of disease; DOD = dead of disease; AWD = alive with disease; DOO = dead of other causes; na = not available